Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.
Andersson NW, Thiesson EM, Baum U, Pihlström N, Starrfelt J, Faksová K, Poukka E, Lund LC, Hansen CH, Aakjær M, Kjær J, Cohet C, Goossens M, Andersen M, Hallas J, Meijerink H, Ljung R, Hviid A.
Andersson NW, et al. Among authors: baum u.
BMJ. 2023 Jul 24;382:e074325. doi: 10.1136/bmj-2022-074325.
BMJ. 2023.
PMID: 37487623
Free PMC article.